Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.420
0.00 (0.00%)
At close: Sep 5, 2025, 4:00 PM
2.550
+0.130 (5.37%)
After-hours: Sep 5, 2025, 7:49 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits | 36.79M | Log In | Log In | Log In | Log In | Upgrade |
Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits Growth | -14.26% | Log In | Log In | Log In | Log In | Upgrade |
Research and Development | 22.56M | Log In | Log In | Log In | Log In | Upgrade |
Research and Development Growth | -17.18% | Log In | Log In | Log In | Log In | Upgrade |
Performance Enzymes | - | Log In | Log In | Log In | Log In | Upgrade |
Performance Enzymes Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Novel Biotherapeutics | - | Log In | Log In | Log In | Log In | Upgrade |
Novel Biotherapeutics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
Americas | 21.28M | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | 54.94% | Log In | Log In | Log In | Log In | Upgrade |
China | 9.80M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -51.72% | Log In | Log In | Log In | Log In | Upgrade |
India | 7.30M | Log In | Log In | Log In | Log In | Upgrade |
Singapore | 6.20M | Log In | Log In | Log In | Log In | Upgrade |
EMEA | 5.16M | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | -54.37% | Log In | Log In | Log In | Log In | Upgrade |
APAC | 4.41M | Log In | Log In | Log In | Log In | Upgrade |
APAC Growth | -66.61% | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | 3.40M | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | -69.37% | Log In | Log In | Log In | Log In | Upgrade |
Ireland | 1.80M | Log In | Log In | Log In | Log In | Upgrade |
Ireland Growth | 260.00% | Log In | Log In | Log In | Log In | Upgrade |